NURSING 6005 CHAPTER 50: PROPHYLAXIS OF CORONARY HEART DISEASE

Document Content and Description Below

NURSING 6005 CHAPTER 50: PROPHYLAXIS OF CORONARY HEART DISEASE: Drugs That Help Normalize Cholesterol and Triglyceride Levels Test Bank MULTIPLE CHOICE 1. A patient with a history of angina an... d hypertension is being started on nicotinic acid (Niacin). The nurse is providing patient education. What statement made by the patient demonstrates a need for further teaching? a. “I will take Tylenol with my medication to reduce the inflammatory effects.” b. “I will be cautious taking this medication, because I have mild liver damage.” c. “I will take an aspirin 30 minutes before my niacin to reduce flushing.” d. “This medication will lower my triglyceride levels.” 2. A prescriber has ordered rosuvastatin (Crestor) for a patient with non–alcoholic-related cirrhosis. Which intervention would be most appropriate for the nurse before administration of this drug? a. Question the order, because rosuvastatin is contraindicated in patients with liver disease. b. No intervention is necessary; just administer the drug as ordered. c. Review the baseline liver function test results. d. Assess the patient for liver disease. 3. A patient with malaise has been taking daptomycin (Cubicin) for an infection and is concurrently taking simvastatin (Zocor). The nurse should be concerned if the patient complains of: a. nausea. b. tiredness. c. muscle pain. d. headache. 4. A patient who recently started therapy with an HMG-COA reductase inhibitor asks the nurse, “How long will it take until I see an effect on my LDL cholesterol?” The nurse gives which correct answer? a. “At least 6 months is required to see a change.” b. “A reduction usually is seen within 2 weeks.” c. “Blood levels normalize immediately after the drug is started.” d. “Cholesterol will not be affected, but triglycerides will fall within the first week.” 5. A patient taking gemfibrozil (Lopid) and rosuvastatin (Crestor) concurrently begins to complain of muscle aches, fatigue, and weakness. What should the nurse monitor? a. For tendon tenderness b. For a lupuslike syndrome c. The patient’s LFT results d. The patient’s creatinine kinase levels 6. A patient presents to the clinic with complaints of muscle aches, muscle pain, and weakness. Upon review of the individual’s medications, the nurse notes that the patient is concurrently taking gemfibrozil (Lopid) and atorvastatin (Lipitor). The nurse should assess the patient for the development of: a. migraines. b. hypothyroidism. c. myopathy. d. heart failure. 7. A patient has begun taking an HMG-COA reductase inhibitor. Which statement about this class of drugs made by the nurse during patient education would be inappropriate? a. “Statins reduce the risk of stroke.” b. “You should come into the clinic for liver enzymes in 1 month.” c. “Statins reduce the risk of coronary events in people with normal LDL levels.” d. “You should maintain a healthy lifestyle and avoid high-fat foods.” 8. A nurse is instructing a patient receiving a cholesterol-lowering agent. Which information should the nurse include in the patient education? a. “This medication will replace other interventions you have been trying.” b. “It is important for you to double your dose if you miss one to maintain therapeutic blood levels.” c. “Stop taking the medication if you experience constipation.” d. “You should continue your exercise program to increase your HDL serum levels.” [Show More]

Last updated: 2 years ago

Preview 1 out of 7 pages